Beyond Biotech - the podcast from Labiotech How to optimize your biotech company for partnering, licensing, and business success
Today, we welcome Janita Good, a Partner at Fieldfisher with nearly two decades of experience advising top organizations in pharmaceuticals, biotechnology, and medical devices. With a D.Phil. in Biochemistry from the University of Oxford, Janita brings a unique blend of scientific insight and legal expertise to her work on venture investments, joint ventures, partnerships, and M&A deals. She's advised on landmark transactions, including funding rounds for Phynova and MedAnnex, and collaborations like Intelligent Ultrasound's AI imaging partnerships.
In this episode, Janita shares practical guidance for biotech leaders on timing partnerships with larger pharma companies, planning for commercialization from the start, balancing optimistic fundraising with realistic deal projections, and avoiding common legal pitfalls in M&A. We'll also look ahead to emerging trends in the sector and talk through the best way to structure a company for tax effective partnering and licensing.
01:29: Meet Janita Good
04:42: Fieldfisher's life sciences focus
07:20: Fieldfisher’s differentiated approach
09:41: Timing early partnering discussions
17:26: Structuring for efficient deals
21:36: Planning commercialization from start
25:22: Key early legal considerations
30:00: Balancing fundraising and realism
36:25: Optimism in the biotech industry
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
To dive deeper into the topic: